Literature DB >> 22267241

Contrast-induced kidney injury: mechanisms, risk factors, and prevention.

Erdmann Seeliger1, Mauricio Sendeski, Charanjit S Rihal, Pontus B Persson.   

Abstract

In general, iodinated contrast media (CM) are tolerated well, and CM use is steadily increasing. Acute kidney injury is the leading life-threatening side effect of CM. Here, we highlight endpoints used to assess CM-induced acute kidney injury (CIAKI), CM types, risk factors, and CIAKI prevention. Moreover, we put forward a unifying theory as to how CIAKI comes about; the kidney medulla's unique hyperosmolar environment concentrates CM in the tubules and vasculature. Highly concentrated CM in the tubules and vessels increases fluid viscosity. Thus, flow through medullary tubules and vessels decreases. Reducing the flow rate will increase the contact time of cytotoxic CM with the tubular epithelial cells and vascular endothelium, and thereby damage cells and generate oxygen radicals. As a result, medullary vasoconstriction takes place, causing hypoxia. Moreover, the glomerular filtration rate declines due to congestion of highly viscous tubular fluid. Effective prevention aims at reducing the medullary concentration of CM, thereby diminishing fluid viscosity. This is achieved by generous hydration using isotonic electrolyte solutions. Even forced diuresis may prove efficient if accompanied by adequate volume supplementation. Limiting the CM dose is the most effective measure to diminish fluid viscosity and to reduce cytotoxic effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22267241     DOI: 10.1093/eurheartj/ehr494

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  118 in total

1.  Identifying the Adamkiewicz artery using 3-T time-resolved magnetic resonance angiography: its role in addition to multidetector computed tomography angiography.

Authors:  Hidenobu Takagi; Hideki Ota; Yutaka Natsuaki; Yoshiaki Komori; Koki Ito; Yoshikatsu Saiki; Kei Takase
Journal:  Jpn J Radiol       Date:  2015-10-26       Impact factor: 2.374

2.  Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.

Authors:  Hidefumi Nakahashi; Masami Kosuge; Kentaro Sakamaki; Masayoshi Kiyokuni; Toshiaki Ebina; Kiyoshi Hibi; Kengo Tsukahara; Noriaki Iwahashi; Shotaro Kuji; Mari S Oba; Satoshi Umemura; Kazuo Kimura
Journal:  Heart Vessels       Date:  2016-04-22       Impact factor: 2.037

3.  Evaluation of intrarenal oxygenation in iodinated contrast-induced acute kidney injury-susceptible rats by blood oxygen level-dependent magnetic resonance imaging.

Authors:  Lu-Ping Li; Jing Lu; Ying Zhou; Maria V Papadopoulou; Tammy Franklin; Ujala Bokhary; Richard Solomon; Anindya Sen; Pottumarthi V Prasad
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

4.  Detailing renal hemodynamics and oxygenation in rats by a combined near-infrared spectroscopy and invasive probe approach.

Authors:  Dirk Grosenick; Kathleen Cantow; Karen Arakelyan; Heidrun Wabnitz; Bert Flemming; Angela Skalweit; Mechthild Ladwig; Rainer Macdonald; Thoralf Niendorf; Erdmann Seeliger
Journal:  Biomed Opt Express       Date:  2015-01-06       Impact factor: 3.732

5.  Renal impairment according to acute kidney injury network criteria among ST elevation myocardial infarction patients undergoing primary percutaneous intervention: a retrospective observational study.

Authors:  Yacov Shacham; Eran Leshem-Rubinow; Arie Steinvil; Eyal Ben Assa; Gad Keren; Arie Roth; Yaron Arbel
Journal:  Clin Res Cardiol       Date:  2014-02-13       Impact factor: 5.460

6.  Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback.

Authors:  Zhi Zhao Liu; Kristin Schmerbach; Yuan Lu; Andrea Perlewitz; Tatiana Nikitina; Kathleen Cantow; Erdmann Seeliger; Pontus B Persson; Andreas Patzak; Ruisheng Liu; Mauricio M Sendeski
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-15

7.  High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.

Authors:  Yacov Shacham; Eran Leshem-Rubinow; Arie Steinvil; Gad Keren; Arie Roth; Yaron Arbel
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

8.  Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials.

Authors:  Xue-Biao Wei; Lei Jiang; Xin-Rong Liu; Dan-Qing Yu; Ning Tan; Ji-Yan Chen; Ying-Ling Zhou; Peng-Cheng He; Yuan-Hui Liu
Journal:  Eur J Clin Pharmacol       Date:  2016-10-01       Impact factor: 2.953

9.  Protective effect of astaxanthin against contrast-induced acute kidney injury via SIRT1-p53 pathway in rats.

Authors:  Dongmei Gao; Hu Wang; Yang Xu; Di Zheng; Quan Zhang; Wenhua Li
Journal:  Int Urol Nephrol       Date:  2018-11-19       Impact factor: 2.370

Review 10.  Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.

Authors:  Benjamin M Yeh; Paul F FitzGerald; Peter M Edic; Jack W Lambert; Robert E Colborn; Michael E Marino; Paul M Evans; Jeannette C Roberts; Zhen J Wang; Margaret J Wong; Peter J Bonitatibus
Journal:  Adv Drug Deliv Rev       Date:  2016-09-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.